Osteoarthritis of the knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Knee pain
Exclusion criteria
Exclusion criteria: artificial replacement of the knees, current use of NSAIDs, current use of steroid, rheumatoid arthritis patients, severe inflammation (ESR>=40mm/h or RF positive), intraarticular injection to the knees within 3 months, abnormal function of liver and kidney (2.5 times or more normal value), intake of alternative medicine (glcosamin, chondroitin sulfate, collagen, and hyaluronic acid) within 4 weeks, remarkable obesity (BMI>30), pregnant or nursing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOMAC score, joint narrowing of the knee (MTP view), SF-36, Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ) | — |
Secondary
| Measure | Time frame |
|---|---|
| Bone metabolic marker (BAP, NTx), cartilage metabolic marker (COMP) | — |
Countries
Japan
Contacts
Osaka City University Hospital Center for Drug & Food Clinical Evaluation